NEURAL STEM CELLS AND THE NEUROGENESIS PROCESS {#sec0005}
==============================================

Neurogenesis is the process of generating new neurons from neural stem cells (NSCs) and their progenitors. NSCs are characterized by the ability to self-renew and by multipotency, enabling the formation of astrocytes, oligodendrocytes and neurons upon differentiation \[[@ref001]\]. In the embryonic mammalian brain, radial glia are the primary precursors of new neurons and astrocytes \[[@ref002]\]. These cells reside in the ventricular zone (VZ) but possess long processes that penetrate the brain parenchyma and contact the pial surface of the brain ([Fig. 1a](#bpl-3-bpl160041-g001){ref-type="fig"}). The early postnatal VZ is largely composed of radial glial cell bodies that remain proliferative, display interkinetic nuclear migration and serve as progenitors of new neurons. In the adult lateral ventricles, a subpopulation of astrocytes derived from radial glia remain in contact with the ventricular lumen, into which they extend a single cilium similar to that found in neuroepithelial cells and radial cells ([Fig. 1a](#bpl-3-bpl160041-g001){ref-type="fig"}). Taken together, current data suggest a continuum between embryonic and adult germinal brain centres\[[@ref004]\].

![The radial glia nature of embryonic and adult neural stem cells: the role of imprinted genes. (a) There is a continuum of germinal activity that links neuroepithelial stem cells to radial glia and ultimately to the astrocytes that are stem cells in the adult brain. Radial glia in the neocortex produce several major brain cell classes, including neurons and astrocytes, *via* several rounds of proliferation and differentiation. The roles of the imprinted genes are indicated. Maternally and paternally expressed genes appear in pink and blue respectively. Imprinted genes that show biallelic expression are in black and bold. (b) Sagittal view showing the SVZ and the SGZ neurogenic niches in the adult mouse brain. In the SVZ, neuroblasts reach the olfactory bulb (OB) through the rostral migratory stream (rms). (c) Enlarged view of the SGZ: Type I stem cells (blue) show a radial single prolongation through the granular layer; type II precursors (purple) give rise to neuronal lineage-restricted progenitor type III cells (red) that differentiate into neurons, which in turn integrate into the granular layer (gr). (d) Enlarged view of the SVZ: type B1 stem cells (blue) contact the ventricle with a thin process extending between the ependymal cells (e; grey); transit-amplifying progenitors (TAP) or type C cells (purple) give rise to type A cells (red) and oligodendrocytes progenitors (yellow). Dividing stem cells and their TAP progeny are tightly apposed to blood vessels (bv); the choroid plexus-cerebrospinal fluid system (cp-CSF) is shown.](bpl-3-bpl160041-g001){#bpl-3-bpl160041-g001}

In the mammalian brain, two regions continue to generate new neurons throughout adulthood: the subventricular zone (SVZ) of the lateral ventricles' wall and the subgranular zone (SGZ) of the dentate gyrus (DG) in the hippocampus ([Fig. 1b](#bpl-3-bpl160041-g001){ref-type="fig"}) \[[@ref006]\]. Adult NSCs originate from embryonic radial glia and thus express astrocytic markers such as the glial fibrillary acidic protein (GFAP) or the astrocyte-specific glutamate transporter known as excitatory amino acid transporters (GLAST) \[[@ref008]\]. Moreover, NSCs are relatively quiescent \[[@ref010]\] and express the transcription factor Sox2 (SRY-related HMG box 2) and the neural progenitor markerNestin \[[@ref011]\].

NSCs in the SVZ are called type B1 cells and give rise to rapid transit amplifying intermediate progenitors or type C cells, which in turn give rise to immature neurons called type A cells or neuroblasts ([Fig. 1d](#bpl-3-bpl160041-g001){ref-type="fig"}). These latter cells migrate obliquely to the olfactory bulb (OB) via the *rostral migratory stream* (rms), where they integrate and mature ([Fig. 1b](#bpl-3-bpl160041-g001){ref-type="fig"}) to generate different kinds of inhibitory interneurons that play an important role in rodent olfaction \[[@ref012]\]. Less frequently, NSCs also support oligodendrogenesis in this region. They are capable of producing oligodendroblasts that migrate to the corpus callosum and striatum, where they differentiate into myelinating and nonmyelinating oligodendrocytes \[[@ref014]\]. However, in humans the functional role of the SVZ neurogenesis is not fully understood. In the SGZ, stem cells are located between the granular layer and the hilus of the DG, next to astrocytes that regulate their proliferation and differentiation. SGZ NSCs (type I cells) exhibit a radial process spanning the granule cell layer and give rise to type II cells, which are positive for the progenitor marker T-box gene-2 (*Tbr2*). Type II cells generate type III cells, which are neuronal precursors ([Fig. 1c](#bpl-3-bpl160041-g001){ref-type="fig"}) and express markers of immature migrating neurons such as doublecortin (DCX) and the polysialylated-neural cell adhesion molecule (PSA-NCAM), which differentiate and integrate in the neuronal circuit in the CA3 region of the hippocampus \[[@ref015]\]. A low percentage of SGZ stem cells also produce oligodendrocytes and astrocytes that migrate into the hilus and the molecular layer \[[@ref016]\]. Integration of newborn neurons into the existing hippocampal neural circuitry plays a crucial role in learning and memory, as well as contributing significantly to hippocampal plasticity throughout the life span \[[@ref006]\].

Given the absence of unique, decisive markers to identify the neural stem cell population *in vivo*, the analysis of NSCs has been widely based on the *ex vivo* behaviour of cells isolated from neurogenic niches. Individual cells dissected from either the postnatal SVZ or SGZ can proliferate in a medium containing basic fibroblast growth factor (FGF2) and/or epidermal growth factor (EGF) to produce multipotent clonal aggregates called "*neurospheres*" \[[@ref017]\]. In proliferating cultures, a NSC must produce a neurosphere that includes cells able to generate new aggregates upon clonal passage (self-renewal). The stem cell forming the initial clone undergoes several symmetrical self-renewing divisions before changing to an asymmetric division. The frequency of long-lived NSCs dissociated from the SVZ/SGZ is often estimated as the number of cells capable of generating such primary spheres. This property allows for the culture's net expansion. Neurospheres can also be induced to differentiate in a culture so as to generate the three major cell types of the central nervous system (CNS): βIII-tubulin+ neurons, GFAP+ astrocytes and O4+ oligodendrocytes \[[@ref017]\]. There is still some controversy about the real functional relationship between neurosphere-forming cells and the stem cell population *in vivo* \[[@ref019]\]. Nevertheless, this system represents a tractable model to investigate the contribution to cell fate specification made by signalling pathways, expression or epigenetic mechanisms, potentially applicable to neural stem cells for restorative neurogenesis in disease or trauma.

EPIGENETIC REGULATION AND MAMMALIAN GENOMIC IMPRINTING {#sec0010}
======================================================

Epigenetic mechanisms are heritable modifications to DNA and chromatin that do not involve changes in the DNA sequence itself but which can modulate gene expression and genome function \[[@ref020]\]. At the molecular level, epigenetic regulation involves chemical modifications to DNA such as methylation and hydroxymethylation, and to the histone proteins around which the DNA is wrapped, including acetylation, methylation, phosphorylation, and ubiquitylation and noncoding RNA (ncRNAs) action. It is becoming apparent that epigenetic modifications to developmental genes are very important cell-intrinsic programs that can interact with transcription factors and environmental cues to modulate cell maintenance and differentiation \[[@ref022]\]. Indeed, epigenetic mechanisms seem to provide means for coordinately activating and repressing arrays of genes at specific steps in a differentiation pathway \[[@ref023]\].

During mammalian development, the vast majority of genes are expressed or repressed from both alleles. However, there are a small number of genes known as imprinted genes that are expressed monoallelically from either the maternally or paternally inherited chromosome \[[@ref025]\]. Approximately 150 imprinted genes have been described in mammals (for a complete list, see <http://www.mousebook.org/mousebook-catalogs/imprinting-resource>) and are generally organised in clusters, although examples of singleton imprinted genes do exist \[[@ref026]\]. These clusters typically contain at least one ncRNA and both maternally and paternally expressed imprinted genes. An imprinting cluster is usually under the control of a DNA element called the imprinting control region (ICR), which consists of a differentially DNA-methylated region (DMR) on the two parental chromosomes ([Fig. 2a](#bpl-3-bpl160041-g002){ref-type="fig"}). Thus, ICRs can be divided into those which are methylated on the paternally-inherited copy and those with maternally-inherited methylation. Imprints are usually established in the germline \[[@ref028]\] and the deletion of a germline-derived ICR results in a loss of imprinting of multiple genes in the cluster \[[@ref025]\] ([Fig. 2b](#bpl-3-bpl160041-g002){ref-type="fig"}).

![Imprinted genes are located in clusters that are under the control of the imprinting control region (ICR). (a) Mammalian somatic cells contain a maternally-inherited chromosome (pink) and a paternally-inherited chromosome (blue). Imprinted genes are located in clusters and can be expressed in the maternally-inherited chromosome and repressed from the paternally-inherited chromosome (green box A), or expressed in the paternally-inherited chromosomes and repressed from the maternally inherited chromosome (red box B). Imprinting in the cluster is regulated by a DNA element called the *imprinting control region* (ICR) that has differentially-methylated regions (DMRs) on the two parental chromosomes. (b) Mutations in the ICR can modify imprinting, thus affecting several genes in the cluster and resulting in a switch in the expression patterns with the paternally-inherited chromosome, thereby acquiring an epigenotype typical in the maternally-inherited chromosome, or *vice versa.*](bpl-3-bpl160041-g002){#bpl-3-bpl160041-g002}

There are also somatic or secondary DMRs that acquire their DMR status after fertilization. Somatic DMRs directly depend on the presence of a germline DMR \[[@ref028]\]. Mapping experiments and germline DMR deletion experiments in mice demonstrate that the primary ICRs are essential to establish monoallelic expression and the secondary somatic DMRs play important roles in maintaining imprints \[[@ref029]--[@ref031]\].

It is well established that these parental-specific marks are assigned in the germline. At this time, both genomes are in distinct compartments and the modifications can be performed according to the sex of the transmitting gametes. During embryogenesis, the primordial germ cells (PGCs), which will give rise to the gametes, have the methylation patterns characteristic of somatic cells. However, in the genital ridges the imprints are erased during gamete formation to allow for re-establishment of new parental-specific marks ([Fig. 3](#bpl-3-bpl160041-g003){ref-type="fig"}). After demethylation and differentiation of the PGCs, methylation is established at the ICRs in an allele-specific manner depending on whether the developing gamete is in the male or female germline. This occurs by a *de novo* methylation process catalysed by the DNMT3a DNA methyltransferase. DNMT3L is a regulatory co-factor of DNMT3a and is also required \[[@ref032]\]. Maternal germline DMRs are found in gene promoters, whereas paternal germline DMRs are found in intergenic regions \[[@ref028]\]. In male and female germ cells, DNA re-methylation occurs at different times of development. Paternal-specific methylation occurs prenatally in prospermatogonia before meiosis in the germline \[[@ref033]\]. In contrast, maternal-specific ICR methylation takes place postnatally in growing oocytes \[[@ref034]\]. We now know that many differentially-methylated regions are established in the germline. However, unlike imprints, they are not sustained after fertilisation \[[@ref035]\]. Following fertilisation, a rapid, extensive reprogramming of the parentally-inherited genomes occurs and most DNA methylation is lost. However, the parental-specific imprint must be maintained during this period of dynamic epigenetic change and a memory of parental origin is propagated into daughter cells during somatic cell division ([Fig. 3](#bpl-3-bpl160041-g003){ref-type="fig"}). Critical factors such as the Kruppel-like zinc finger protein ZFP57 protect imprints during the post-fertilisation epigenetic reprogramming period \[[@ref036]\]. Somatic heritability is conferred by the DNMT1 DNA methyltransferase. DNMT1 acts with a maintenance function that recognizes newly replicated hemi-methylated DNA and places methylation on the newly replicated strand \[[@ref037]\]. Indeed, DNMT1 and ZFP57 are repressed in PGCs, allowing new imprints to be established during gamete formation \[[@ref038]\].

![Establishment and maintenance of imprints during development. DNA methylation is erased in PGCs in the genital ridge. However, imprints are maintained in somatic cells throughout the organism's lifetime. Imprints are acquired in a sex-specific manner in the germline: maternally and paternally-methylated ICRs gain DNA methylation in oocytes and sperm respectively for transmission to the next generation. Following fertilisation, the parental-specific imprints are maintained in the developing organism despite genome-wide reprogramming elsewhere. ZFP57 protects imprints during the post-fertilization epigenetic reprogramming period. DNMT3a and DNMT3L catalyse the *de novo* methylation process and DNMT1 participates in maintaining imprints in somatic tissues.](bpl-3-bpl160041-g003){#bpl-3-bpl160041-g003}

GENOMIC IMPRINTING AND THE MAINTENANCE OF NEURAL STEM CELLS {#sec0015}
===========================================================

Recent evidence suggests that the genomic imprinting process can be selectively lost or "*switched off*" in particular cell types or at specific developmental points in time to activate an allele that is usually repressed by imprinting \[[@ref039]\]. These heritable changes might be reversible and context-dependent, have an impact on stem cell plasticity and are likely to be essential for normal development and tissue regeneration \[[@ref041]\]. Selective regulation of imprinting is probably a normal mechanism for modulating gene dosage to control stem cell potential in brain development and within the neurogenic niches throughout development and adult life \[[@ref039]\].

Genomic imprinting in early development {#sec0020}
---------------------------------------

During cortical neurogenesis, radial glia highly express the paternally-expressed zinc finger protein *Zac1* \[[@ref043]\]. Elevated *in vivo* levels of ZAC1 promote cell cycle exit, disrupt neurogenesis and provoke a partial switch from neural to mesodermal/myogenic lineage with additional expression of pluripotency genes \[[@ref043]\]. Moreover, overexpressing *Zac1* induces the expression of other imprinted genes such as the maternally-expressed cyclin-dependent kinase inhibitor *Cdkn1c*, known to promote NSC cell cycle arrest and proglial differentiation \[[@ref043]--[@ref046]\]. Recent evidence suggests that some ncRNAs regulate imprinting by fine-tuning the gene expression of the protein-coding genes to maintain their dosage in cells \[[@ref047]\]. For example, miR134, an imprinted miRNA belonging to the miR379--410 cluster, promotes cell proliferation and reduces cell migration *in vivo* \[[@ref048]\]. Additionally, miR369-3p, miR496 and miR543, also belonging to the miR379--410 cluster, bind directly to the 3^′^UTR of the *Ncad* transcript and fine-tune the expression level of *N-cadherin* in VZ progenitors to control neuronal differentiation and migration \[[@ref049]\]. Furthermore, miR369-3p has been shown to regulate the expression of *Adam10* and *TrappC8* during development of the neocortex \[[@ref049]\]. Finally, the proliferative capacity of cortical progenitors in the embryonic mouse neocortex is repressed by paternal expression of *Necdin*, which is moderately expressed in the ventricular zone of the murine embryonic neocortex. *Necdin* suppresses neural progenitor proliferation by interacting with the polycomb protein Bmi1 \[[@ref050]\]. These data show that imprinted genes regulate foetal neural stem cell activity in early neurodevelopment.

Imprinted genes and adult neurogenesis {#sec0025}
--------------------------------------

In the adult brain, NSCs persistently generate new neurons in the SVZ and SGZ niches. In the SVZ, the paternally-expressed gene *Delta-like homologue 1* (*Dlk1*), an atypical Notch ligand located on mouse chromosome 12 (human chromosome 14), plays an important dual function to regulate postnatal neurogenesis. Importantly, *Dlk1* is a single gene that encodes for both a secreted factor (expressed by niche astrocytes) and a bound receptor (expressed by neural stem cells). *Dlk1*, which is a canonically imprinted gene elsewhere in the brain, shows a selective absence of imprinting in these cell types. Biallelic expression of *Dlk1* is required for stem cell maintenance in the SVZ and final neurogenesis to the olfactory bulb \[[@ref039]\]. This selective absence of *Dlk1* imprinting in NSCs is associated with acquisition of DNA methylation in the germline-derived imprinting control region \[[@ref039]\]. Notably, canonical imprinting of *Dlk1* is maintained in foetal stem cells, indicating that imprinting relaxation occurs postnatally. The *Dlk1* neighbouring gene, *Gtl2*, or the unlinked *Snrpn* located on chromosome 7C, keep their imprinting in the neurogenic zone, suggesting a selective gene-specific regulation of the absence of imprinting \[[@ref039]\].

*Insulin-like growth factor 2* (*Igf2*), which is canonically expressed from the paternally-inherited allele, is biallelically expressed in the choroid plexus and secreted to the cerebrospinal fluid to regulate NSC proliferation and to promote foetal cortical neurogenesis \[[@ref051]\]. *Igf2* is also biallelically expressed in the postnatal human and mouse choroid plexus epithelium and leptomeninges \[[@ref052]\]. As in the embryonic brain, biallelic expression in the adult choroid plexus and SVZ vasculature acts as a paracrine factor that regulates NSC homeostasis. In contrast, *Igf2* is imprinted in the hippocampus and acts as an autocrine factor expressed in the SGZ neural stem cells solely from the paternal allele \[[@ref040]\]. Hence, like *Dlk1*, selective absence of *Igf2* imprinting is required for SVZ neurogenesis; however, in contrast to *Dlk1*, imprinted *Igf2* is also required for SGZ neurogenesis. Furthermore, conditional mutagenesis of *Igf2* in blood vessels has confirmed that endothelial-derived IGF2 contributes to NSC maintenance in the SVZ but not in the SGZ \[[@ref040]\]. These data demonstrate that *Igf2* is highly dosage-sensitive and that the distinct regulatory processes and mechanisms are unique to each neurogenic niche. In the SGZ, long-term deletion of the maternally expressed, *cyclin-dependent kinase inhibitor* (*Cdkn1c*) gene leads to NSC exhaustion and impaired neurogenesis in aged mice \[[@ref054]\] showing that *Cdkn1c* also promotes NSCs quiescence.

Several micro RNAs have been described as having a role in adult NSCs. For example, the paternally-expressed miR-184, located at chromosome 9, promotes proliferation and inhibits differentiation of NSCs in the adult SGZ \[[@ref055]\]. Mir-184 is directly repressed by the methyl-CpG binding protein 1 (MBD1) and it regulates the expression of Numblike by binding to the 3\'-UTR of *Numbl* mRNA, affecting its translation \[[@ref055]\]. The maternally expressed Mir-410, located at chromosome 12, is repressed by the neural inducer Noggin, causing the inhibition of neuronal and oligodendrocyte differentiation by promoting an astroglial fate \[[@ref056]\].

Epigenetic regulation of imprinting in neurogenesis {#sec0030}
---------------------------------------------------

The precise epigenetic modifications regulating the ICRs result in changes in the appearance and structure of DNA. DNA is methylated and then allele-specific histone modifications are recruited \[[@ref057]\]. The enzymes that establish and maintain DNA methylation-specific patterns, including *de novo* DNA methyltransferases *Dnmt3a* and *Dnmt3b* and the maintenance *Dnmt1*, are highly expressed in postnatal NSCs and are required for neurogenesis and neuronal maturation \[[@ref058]\]. Furthermore, depletion of DNMT3b leads to deficient neuronal differentiation *in vitro* \[[@ref060]\]. DNMT1 is highly expressed in the embryonic, perinatal and adult CNS in both dividing neural progenitors and mature neurons \[[@ref058]\]. In support of this, mice lacking *Dnmt1* specifically in neural precursor cells at E9--\#x2013;\#x2013;E10 exhibit deficits in neuronal function and die postnatally, suggesting a requirement for methylation in brain development \[[@ref063]\]. A role for DNMT3a has also been demonstrated in postnatal neurogenesis \[[@ref064]\], though the specific role of these molecules in the maintenance of imprinting marks in adult NSCs has not been well described. The N-terminal tails of histones are subject to post-translational modifications, including acetylation, methylation or phosphorylation; modifications that regulate the genomic accessibility and provide a scaffold to bind other factors to control the activation or repression of associated genes. Although several studies have implicated histone acetylation in regulating adult neurogenesis \[[@ref065]\], the role of histone modifications in imprinting control is less clear. Notably, DMRs are characteristic for the asymmetrical accumulation of different histone modifications in the two parental chromosomes and the identification of a '*tri-mark*' comprising the trimethylation of H3K4, H3K9 and H4K20 at all known ICRs, which has reignited the debate about the role of histone modifications in imprintingcontrol \[[@ref067]\].

ABERRATIONS OF GENOMIC IMPRINTING {#sec0035}
=================================

Disruption of imprinting in neurodevelopment {#sec0040}
--------------------------------------------

The epigenetic imprints established in the germline are maintained throughout development and adult life. Abnormalities in imprints are associated with perturbations in growth, placental function, postnatal adaptations and neurobehavioural processes. Moreover, imprinted genes are expressed widely and highly during prenatal stages but predominantly down-regulate after birth. They are involved in multiple developmental processes capable of affecting organ development and growth. After birth, imprinted genes modulate postnatal neurological and metabolic functions. Their monoallelic expression makes these *loci* very vulnerable since mutation or loss of imprinting of the expressed allele can compromise expression and lead to severe developmental defects \[[@ref068]\]. The majority of imprinted genes are expressed in the placenta and brain \[[@ref069]\]. Disruption of imprinting can result in a number of human congenital imprinting syndromes including Prader-Willi (PWS) and Angelman syndromes (AS), characterised by neurological and behavioural impairments and learning difficulties \[[@ref071]\]. These distinct disorders map to the same imprinted domain on the human chromosome 15q \[[@ref072]\]. Patients with PWS show mild mental retardation and behavioural problems, along with other symptoms. Paternally-expressed transcripts from the PWS/AS locus, including the protein-coding SNRPN gene, are not expressed in PWS and are implicated in the syndrome, although their precise contribution to the aetiology of the disorder is not known. Angelman Syndrome, in contrast, is associated with an absence of the UBE3A transcript, which is expressed from the maternally inherited chromosome. *U be3a*-maternal-deficient mice (AS model mice) show a significant impairment in adult hippocampal neurogenesis that could contribute to the cognitive disturbances observed in these mice \[[@ref073]\]. However, little is known about how the absence or altered dosage of these genes in neural stem cell populations influences neuronal function. Other imprinted disorders such as Temple and Kagami-Ogawa Syndromes, associated with the altered dosage of imprinted genes on human chromosome 14, also exhibit neurological and behavioural impairments \[[@ref074]\]. This further emphasizes the importance of correct regulation of imprinted genes during the neurogenesis process and in neural development.

Aberrations of genomic imprinting in brain cancer stem cells {#sec0045}
------------------------------------------------------------

The discovery of multipotent stem cells and restricted progenitors in the postnatal mammalian brain and the identification of stem-like cells in several brain tumours have led to the development of the "*cancer stem cell*" (CSC) theory of gliomas. This theory posits that gliomas are the result of the malignant transformation of cells deriving from the NSCs or lineage-restricted progenitor populations, rather than from the de-differentiation of mature cell populations \[[@ref075]\]. The existence of cancer stem cells has been proven in brain tumours in which a small population of cells (less than 1%) shows the potential to give rise to the growing tumour. These cells have substantial stem cell characteristics such as self-renewal without loss of proliferation capacity or plasticity (capacity to change their fate and adopt a new identity). These behaviours are equally important in physiological regeneration processes and carcinogenesis. Gliomas have been shown to orchestrate a microenvironment by mimicking the normal neural stem cell niche, thereby helping to maintain the 'glioma-initiating' stem cell pool \[[@ref076]\]. Furthermore, glioma-initiating cells are immortal, quite resistant to treatment and express markers typical of tumour stem cells.

Several epigenetic marks, especially DNA methylation and histone modification patterns, become altered in tumour progression and lead to changes in gene expression \[[@ref077]\]. These changes affect the whole epigenome and thus cellular identity. However, whether the cancer stem cells originate from normal stem cells as a consequence of genetic and epigenetic changes and/or re-differentiation from somatic tumour cells to the stem-like cells remains to be investigated. Several imprinted genes have been shown to function as cellular mitogens or tumour suppressors \[[@ref078]\]. Indeed, disruption of imprinting can cause a predisposition to tumour formation and loss of imprinting in several genes, which has been observed in human cancers \[[@ref080]\], making aberrations in imprinting a potentially valuable tool for both diagnosis and treatment. Imprinted genes of maternal and paternal origin favour different degrees of neural stem cell proliferation. DLK1, essential for maintaining the stem cell pool in the SVZ, is more highly expressed in human glioma \[[@ref082]\]. Loss of imprinting of other genes such as *IGF2* has also been observed in human cancers \[[@ref081]\] and abnormal regulation of the *PEG3* gene is associated with several glioma subtypes \[[@ref083]\]. Thus, an understanding of the mechanistic similarities between normal tissue stem cells and cancer stem cells in the CNS and their epigenetic signatures (including aberrations of imprinting) will be helpful in determining changes that might be involved in the development of human glioblastoma. Such analyses may prove fundamental in understanding stem cell regulation, the nature of cancer/tumour formation, and the future therapeutic use of stem cells in human disease.

CONCLUDING REMARKS {#sec0050}
==================

Loss or gain of genomic imprinting is used as a dynamic developmental mechanism to control gene dosage in NSCs. This implies that the epigenetic mechanisms controlling genomic imprinting may be adaptable to the environmental niche in which they are acting, contributing to the regulation of non-imprinted *loci* in the brain, too. It now becomes important to understand the epigenetic profile and some of the molecular players that participate in the regulation of the imprinting status in NSCs, as well as the role of these imprinting domains in the maintenance of the stem cell pool in the neurogenic niches *in vivo*. Dissecting the molecular players that participate in the preservation of the imprints at ICRs during postnatal neurogenesis under normal physiological conditions is also relevant and has the potential to provide insights into the wider epigenetic control of the neurogenic process. Moreover, the molecular mechanisms underlying normal NSC function may be the non-pathological counterparts to the tumoural processes in the adult brain. Thus, whether cancer stem cells originate from normal neural stem cells as a consequence of genetic and epigenetic changes in the brain, including aberrations of imprinting, remains to be investigated further.
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